UK markets open in 4 minutes
NIKKEI 225
37,934.76 +306.28 (+0.81%) HANG SENG
17,708.59 +424.05 (+2.45%) CRUDE OIL
83.94 +0.37 (+0.44%) GOLD FUTURES
2,353.00 +10.50 (+0.45%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,498.70 +152.78 (+0.30%)
Sumitomo Pharma Co., Ltd. (DNPUF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 09:54AM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.02B |
| Enterprise value | 3.40B |
| Trailing P/E | N/A |
| Forward P/E | 15.22 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.50 |
| Price/book (mrq) | 0.48 |
| Enterprise value/revenue | 0.01 |
| Enterprise value/EBITDA | -0.03 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.59 |
| 52-week change 3 | -55.67% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 6.2100 |
| 52-week low 3 | 2.2700 |
| 50-day moving average 3 | 2.4188 |
| 200-day moving average 3 | 3.2333 |
Share statistics
| Avg vol (3-month) 3 | 814 |
| Avg vol (10-day) 3 | 1.05k |
| Shares outstanding 5 | 397.29M |
| Implied shares outstanding 6 | 406.6M |
| Float 8 | 179.4M |
| % held by insiders 1 | 57.59% |
| % held by institutions 1 | 16.53% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.1 |
| Forward annual dividend yield 4 | 4.05% |
| Trailing annual dividend rate 3 | 7.00 |
| Trailing annual dividend yield 3 | 259.26% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 87.75% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 30 Mar 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -52.59% |
| Operating margin (ttm) | -37.93% |
Management effectiveness
| Return on assets (ttm) | -11.64% |
| Return on equity (ttm) | -34.90% |
Income statement
| Revenue (ttm) | 330.31B |
| Revenue per share (ttm) | 831.40 |
| Quarterly revenue growth (yoy) | -41.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -188.88B |
| Net income avi to common (ttm) | -173.72B |
| Diluted EPS (ttm) | -2.8300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 42.81B |
| Total cash per share (mrq) | 107.75 |
| Total debt (mrq) | 411.84B |
| Total debt/equity (mrq) | 119.86% |
| Current ratio (mrq) | 0.63 |
| Book value per share (mrq) | 864.73 |
Cash flow statement
| Operating cash flow (ttm) | -275.33B |
| Levered free cash flow (ttm) | -152.23B |
© 2024 Yahoo. All rights reserved.